CIPROFLOXACIN KABI

200MG/100ML INF SOL 10X100ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 06.05.2021
Interruption of marketing 28.04.2021 0162187, 0059830
Capacity/distribution reasons 05.05.2021
Resumption of marketing 16.04.2020
Interruption of marketing 18.03.2020 0059830
Capacity/distribution reasons 10.04.2020
Resumption of marketing 15.02.2011
Interruption of marketing 15.02.2011 0125255
Placing on the market 20.05.2010

All reports are available in the Overview.

Back to list